Companies in #Addiction Medicine

Clinical-stage biopharmaceutical company developing small-molecule sequestrant-based therapies designed to capture and clear harmful substances from the body, with a focus on drug overdose reversal and CNS dysfunction.

Indivior PLC (NASDAQ: INDV) is a specialty pharmaceutical company singularly focused on opioid use disorder (OUD), developing and commercializing evidence-based treatments such as the once-monthly injection Sublocade to support long-term recovery.